Pay in 4 interest-free payments of $9.75 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
SP and the NK1-R are internalized into the same clathrin immunoreactive vesicles
PubMed PMID: 27159577
Smiles: CN(C1=CC(=CC=C1)C1=CC=NC2=C(C=NN12)C(=O)C1=CC=CS1)C(C)=O
Mol Endocrinol
Direct activation of the apoptosis machinery as a mechanism to target cancer cells
LDN-214117 - CAS# 1627503-67-6 60245 SP and the NK1-R areLDN 214117, CAS No. 1627503 67 6, is a selective and potent ALK2 inhibitor. LDN 214117 inhibited ALK2 most, with a biochemical IC50 of 24 nM. There are currently no effective therapies for fibrodysplasia ossificans progressiva (FOP), a debilitating and progressive heterotopic ossification disease caused by activating mutations of ACVR1 encoding the BMP type I receptor kinase ALK2. LDN 214117 shows a high degree of selectivity for ALK2 and low